A woman’s speech issues, initially attributed to menopausal symptoms, turned out to be a sign of an incurable brain cancer diagnosis. Michelle Dilger, aged 52, was diagnosed with glioblastoma and given a year to live, after her speech concerns were dismissed as menopause-related by doctors. Only when a gynaecologist identified her symptoms did she undergo an emergency scan, revealing the cancer. Following surgery at John Radcliffe Hospital in Oxford, Michelle has surpassed expectations, living for eight years and inspiring her son, Jack Dilger, to support cancer research.
Jack, 29, pledged to donate a portion of sales from his sports brand, Cramp Killa, to Brain Tumour Research after witnessing his mother’s battle. Motivated by her resilience, Jack emphasized the brand’s purpose beyond sports performance, aiming to contribute to brain tumour research funding. Inspired by a friend’s triumph over brain tumours, Jack aims to unite the endurance sport community in supporting the cause, highlighting the need for increased research investment in brain tumours. Brain Tumour Research’s CEO, Dan Knowles, commended the partnership with Cramp Killa, emphasizing the importance of research funding for developing improved treatments and ultimately finding a cure.
